SOLUtion Medical is making patient-injected lyophilized drug delivery safer, more efficacious, and easier by developing a one-step, pre-filled reconstituting autoinjector.

Worldwide healthcare is trending toward more at-home treatments, and blockbuster drugs are continually threatened by the emergence of numerous competitors. SOLUtion Medical provides a differentiated delivery system with improved patient safety characteristics that can protect existing revenue streams through regulatory and patent extensions or differentiate competitive products through its patent-pending technology. SOLUtion’s beachhead market is a rescue autoinjector for individuals at risk of an adrenal crisis, a situation similar to anaphylaxis where a patient’s body experiences physical and mental debilitation requiring an immediate injection of hydrocortisone sodium succinate (HSS). In addition to the adrenal crisis rescue injection market, numerous drugs currently exist that must be mixed directly prior to injection. We envision our device as a platform that can be used for other future indications including antipsychotic drugs, in vitro fertilization drugs, monoclonal antibodies, and cancer treatments.

Sector: Healthcare
Sub Sector: Medical Devices
Industry: Healthcare
Status: Active
County: Montgomery

Contact Information

Julia Anthony

Founder, President, and Chief Strategy Officer



David Palling, PhD

VP of CMC and Supply Chain

Mikael Avery

Director of Innovation and Human Factors